November 20, 2003

Hilton Gaithersburg Washington D.C./North, Grand Ballroom, 620 Perry Parkway, Gaithersburg, MD.

9:00 5:00 PMA Discussion, Recommendations, and Voting


9:00 a.m. Call to Order Warren K. Laskey, M.D.

Acting Chairperson


9:05 9:30 a.m. *Open Public Session*


9:30 11:00 a.m. Sponsor Presentation: Boston Scientific Corporation

P030025: Taxus Express2 Paclitaxel-Eluting Coronary Stent Systems


11:00 11:15 a.m. Questions and Answers


11:15 11:30 a.m. Break


11:30 12:30 p.m. FDA Presentation


12:30 12:45 p.m. Questions and Answers


12:45 p.m. Adjourn Break for Lunch


1:45 2:45 p.m. Call to Order


2:45 3:45 p.m. Open Committee Discussion Warren K. Laskey, M.D.


3:45 4:00 p.m. Break


4:00 5:00 p.m. *Open Public Session*

FDA Comments

Sponsor Comments

Recommendations & Vote Warren K. Laskey, M.D.


5:00 p.m. Adjourn




Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.


Ms. Wood will present the speakers who have requested time for presentation to the Panel. After the scheduled speakers have spoken, the Chair may ask them to remain if the committee wishes to question them further. Dr. Laskey will recognize unscheduled speakers as time allows.


Note: Only the Chair and members of the Panel may question speakers during the open public hearing.